Avion Pharmaceuticals, LLC, announces the launch of Prenate® Enhance and Prenate® Restore
ATLANTA, Jan. 21, 2014 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced the launch of two advanced vitamin formulations as the newest additions to the Prenate® Vitamin Family. Prenate® Enhance and Prenate® Restore have been designed to support important nutritional supplementation for women during their prenatal and postpartum period, as well as provide the optimal level of vitamins and minerals recommended.
- Prenate Enhance and Prenate Restore are advanced prescription dietary supplements designed for enhanced absorption with ingredients selected for their high absorbability.
- Prenate Enhance and Prenate Restore provide the highest DHA content (400 mg) among leading prescription prenatal and postnatal vitamins.1-15
- Prenate Enhance and Restore also include Formical®(calcium formate),a patented form of calcium that is better absorbed than calcium citrate and calcium carbonate.16
- Both products provide proprietary Quatrefolic® , a source of folate that is approximately seven times more bioavailable than folic acid.17
Prenate Restore, the first prescription postnatal dietary supplement with probiotics, designed for postpartum supplementation, helps support the needs of both moms and babies post-pregnancy when nutritional stores can often be depleted.
"Avion is excited to be a leader in innovation for the women's health category by providing two new prescription supplements that have been formulated based on expert recommendations for nutritional supplementation for women both pregnant and postpartum. Prenate Enhance and Prenate Restore were designed for nutritional support for both moms and babies during this important period in their life," stated Mike Sullivan, Vice President, Sales and Marketing for Avion Pharmaceuticals.
Avion CEO Mark Pugh added, "Avion Pharmaceuticals has worked diligently to formulate and develop products based on gaps in the women's health category. Avion is the first company to provide a prescription supplement with probiotics for moms and babies during the postpartum period when rebuilding nutritional stores to support both mom and baby is critical. Our goal continues to be to understand women's health needs and match products that deliver positive support to help ensure improved quality of life for women of all ages and life stages."
About Avion Pharmaceuticals, LLC.
Avion Pharmaceuticals, LLC., is a Specialty Pharmaceutical company formed to develop and market a portfolio of innovative products in the Women's Heath and Dermatology therapeutic areas. Avion Pharmaceuticals focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available therapeutics and late-stage development drugs to fulfill unmet medical needs. For additional information about Avion Pharmaceuticals please contact the company at 678-325-5188. For any questions of additional information about Formical® please contact Raj Riswadkar, Senior Vice President at Novadiol, Inc. 314.600.6027
References: 1. Prenate® Enhance prescribing information, Avion Pharmaceuticals, LLC, 2013. 2. Prenate® Restore prescribing information, Avion Pharmaceuticals, LLC, 2013. 3. Prenate® Mini prescribing information, Avion Pharmaceuticals, LLC, 2013. 4. Prenate® DHA prescribing information, Avion Pharmaceuticals, LLC, 2012. 5. Prenate® Essential prescribing information, Avion Pharmaceuticals, LLC, 2012. 6. Prenate® AM prescribing information, Avion Pharmaceuticals, LLC, 2013. 7. Prenate® Chewable prescribing information, Avion Pharmaceuticals, LLC, 2013. 8. Prenate® Elite prescribing information, Avion Pharmaceuticals, LLC, 2012. 9. Nexa® Plus prescribing information, Upsher-Smith Laboratories, Inc., 2012. 10. OB Complete™ ONE prescribing information, Vertical Pharmaceuticals, Inc., 2010. 11. CitraNatal Harmony® prescribing information, Mission Pharmacal Company, 2012. 12. Vitafol®-ONE prescribing information, Everett Labs, 2012. 13. Vitafol®-Ultra prescribing information, Everett Labs, 2013. 14. PreferaOB ONE® prescribing information, Alaven Pharmaceutical, 2012. 15. OB Complete™ Petite prescribing information, Vertical Pharmaceuticals, Inc., 2012.
16. Hanzlik RP, Fowler SC, Fisher DH. Relative bioavailability of calcium from calcium formate, calcium citrate, and calcium carbonate. J Pharmacol Exp Ther. 2005; 313(3):12171222
17. Willems F, Boers G, Blom H, Aengevaeren W, Verheugt F. Pharmacokinetic study on the utilisation of 5-methyltetrahydrofolate and folic acid in patients with coronary artery disease. Br J Pharmacol. 2004; 141:825–830.
PRENATE® is a registered trademark of Acella Pharmaceuticals, LLC. Under license from Acella Pharmaceuticals, LLC. All rights reserved.
Formical® is a registered trademark of Nephro-Tech 1, LLC, covered by one or more claims of U.S. Patent No. 6,528,542
Quatrefolic® is a registered trademark of Gnosis, SpA, covered by one or more claims of U.S. Patent # 7,947,662 CAS# 1181972-37-1
LactoSpore® is a registered trademark of Sabinsa Corporation.
Marketed by Avion Pharmaceuticals LLC, Atlanta, GA 30350 1.888.61.AVION © 2013 Avion Pharmaceuticals Rev. 1113 AV-111
THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE.
SOURCE Avion Pharmaceuticals, LLC